NAS
TEVA icon

Nykredit A/S’s Teva Pharmaceuticals TEVA Stock Holding History

Nykredit A/S’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Buy
+443,442
New +$14.8M 0.05% 290

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nykredit A/S's TEVA Position: Q2 2026 in Review

Nykredit A/S opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 443,442 shares worth $15M. The stake represents 0.05% of the portfolio and ranks #290 among its holdings.

523 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Nykredit A/S held 443,442 shares of Teva Pharmaceuticals worth $15M as of Q2 2026.
  • Teva Pharmaceuticals was a new Nykredit A/S position in Q2 2026.
  • Teva Pharmaceuticals made up 0.05% of Nykredit A/S's portfolio in Q2 2026, its #290 holding.
  • 523 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.